Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J. Miantezila-Basilua"'
Publikováno v:
Médecine et Maladies Infectieuses. 47:S71-S72
Introduction L’efficacite virologique de la combinaison sofosbuvir/ledipasvir en fait a ce jour le traitement de premier choix dans l’infection par le VHC bien que sa tolerance reste encore faiblement documentee. L’objectif principal de cette e
Autor:
Pierre-Marie Girard, J. Miantezila-Basilua, Sylvie Lang, Dominique Costagliola, Christian Funck-Brentano, Emmanuel Teiger, Murielle Mary-Krause, M. Guiguet, F. Boccara, Ariel Cohen
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 9:110
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Terzić V; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Miantezila Basilua J; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Billard N; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France., de Gastines L; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Belhadi D; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France.; Université Paris Cité, IAME, INSERM, Paris, France., Fougerou-Leurent C; Pharmacology Unit, University Hospital Rennes, CIC Inserm 1414, University Hospital Rennes, Rennes, France., Peiffer-Smadja N; Infectious Diseases Department, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.; Université Paris Cité, IAME, INSERM, Paris, France., Mercier N; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France., Delmas C; Pôle de Recherche Clinique, INSERM, Paris, France., Ferrane A; Pôle de Recherche Clinique, INSERM, Paris, France., Dechanet A; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France., Poissy J; UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, Inserm U1285, CHU Lille, Pôle de réanimation, CNRS, Lille, France., Espérou H; Pôle de Recherche Clinique, INSERM, Paris, France., Ader F; Département des Maladies infectieuses et tropicales, Hospices Civils de Lyon, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Univ Lyon, Lyon, France., Hites M; Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB)-Erasme, Brussels, Belgium., Andrejak C; Pulmonolgy Unit, University Hospital Amiens-Picardie, UR 4294 AGIR, Université Picardie Jules Verne, Amiens, France., Greil R; IIIrd Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-Center for clinical Cancer and Immunology Trials (SCRI-CCCIT), Cancer Cluster Salzburg, Austrian Group for Medical Tumor Therapy (AGMT), Salzburg, Austria., Paiva JA; Serviço de Medicina Intensiva, Centro Hospitalar Universitário São João, Porto, Portugal., Staub T; Infectious Diseases Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg., Tacconelli E; Infectious Diseases, Dept. Diagnostic and Public Health, University of Verona, Verona, Italy., Burdet C; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France., Costagliola D; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France., Mentré F; Department of Epidemiology, Biostatistics and Clinical Research, Hospital Bichat, APHP, Paris, France.; Université Paris Cité, IAME, INSERM, Paris, France., Yazdanpanah Y; Université Paris Cité, IAME, INSERM, Paris, France.; Infectious Diseases Department, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.; ANRS|Emerging Infectious Diseases, Paris, France., Diallo A; Clinical Trial Safety and Public Health, ANRS|Emerging Infectious Diseases, Paris, France.; Clinical Research Safety Department, INSERM, Paris, France.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 382-391.